BioCardia BCDA
NASDAQ BCDA
$1.01 -0.02 (-1.94%)
As of: Sep 30, 2026 · 2:50 PM EDT

BioCardia (BCDA) Notes Payables (2010 - 2020)

Updated

BioCardia (BCDA) reported Notes Payables of $284,000 for Q3 2020, up 25.7% from the prior quarter.

Analysis

BioCardia (BCDA) Notes Payables (2010 - 2020) Analysis & Trends

At the end of FY2010, BioCardia posted Notes Payables of $300,000.

  • The Q3 2020 figure ranks as the highest quarterly Notes Payables since Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 BioCardia 12.46 Mn -407,934.31 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 284,000.00
Jun 30, 2020 226,000.00
Dec 31, 2010 300,000.00
API Access

BioCardia Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=BCDA&period=max&api_key=YOUR_API_KEY